Projects
Management agreement with the Center for Cancer Research as an organization with field work for the cancer screening programs Ghent University
Implementation of population screening for breast, cervical and colorectal cancer - year 2024 Ghent University
This project involves the organisation and implementation of the population screening programs for breast, cervical and colorectal cancer. More specifically, we aim to coordinate the screening programs; inform and promote the target public about the screening programs; assess and assure the quality of the cancer screening programs; support the partners involved; and conduct epidemiological research on cancer screening participation and ...
Inequalities in cancer screening and the development of tailored interventions Ghent University
Literature shows important social inequalities in cancer screening participation. This is problematic as cancer screening offers a unique prevention opportunity and reduces cancer incidence, morbidity and mortality. Yet, screening programmes are only effective if every phase in the screening process is optimally addressed. Yet, in the Flemish context, 19.7% of all abnormal pap smears does not receive proper diagnostic evaluation. Therefore, ...
Implementation of population screening for breast, cervical end colorectal cancer - year 2023 Ghent University
A population-based screening is a systematic offer of screening to a population group with predetermined common characteristics. For example, it may involve women and/or men belonging to a certain age group. Population screening involves screening for a disease (e.g. breast cancer) or a precursor of a disease (e.g. colon polyps) or for a health risk (e.g. an unhealthy lifestyle), without any health complaints related to the disease, precursor ...
Health economic aspects of screening for cancer in Flanders Ghent University
1) A systematic review and critical assessment of recent (<3 years) 'best evidence' cost-effectiveness studies of screening for breast, cervical and colorectal cancer in Europe. 2) Economic evaluation of during the preliminary phase of the proposed health conference preventiestragieën and actions to achieve these strategies, with a view to prioritizing organize screening for breast, cervical and colon cancer in Flanders. Based on further ...
Plasma cfRNA biomarker tail genes for cancer screening and monitoring Ghent University
Circulating nucleic acids in blood plasma form an attractive resource to study human health and disease. We examined plasma cell-free RNA profiles for a variety of cancer types and demonstrated the potential of using patient-specific alterations in cell-free RNA profiles for discriminating cancer patients from controls. This method could open novel opportunities for cancer screening and therapy response monitoring. While the method has been ...
Operational implementation and quality assurance of the Flemish Breast Cancer Screening Programme. Ghent University
CPVOK (Centre for Prevention and Early Detection of Cancer), together with four similar centres, ensures the implementation and the quality assurance of the Flemish Breast Cancer Screening Programme. This screening programme is offered to the 50-69 years old female target population using the existing network of mammography units that are recognized for screening by the Flemish Government.
Screening for inhibitors of protein phosphatases that induce mitotic cell death in cancer cells KU Leuven
To this day, cancer is a prevalent disease that accounts for a significant portion of the mortality that is seen in the modern world. The taxanes and vinca alkaloids play a prominent role in the treatment of many types of cancer. These molecules kill cancer cells in mitosis by chronicly activating the spindle assembly checkpoint (SAC) and subsequently inducing mitotic cell death (MCD). However, the clinical use of these molecules has two ...